SlideShare a Scribd company logo
Ischaemic Heart Disease (IHD)
Dr.A.T.M.Mahfuzul Hoque
M D (Cardiology)
Asst. Prof.
Department of Cardiology
Dhaka Medical College& Hospital
Definition & clinical presentation of IHD :
Def. of IHD: Disease of the heart muscle
resulting from myocardial ischaemia
Clinical presentation:
1) Stable Angina
2) Unstable Angina
3) Myocardial infarction (MI) -
* Non ST elevation MI
* ST elevation MI
CORONARY CIRCULATION
Two major coronary
arteries
1. Right coronary
artery
*Arises from- RSV
*Supplies- SA node,
AV node & bundles,
RV , LV inferior wall
CORONARY CIRCULATION
2. Left coronary artery
Arises from- LSV
Two branches-
a). Anterior descending
Supplies- IVS & anterior
wall of LV
b). Left circumflex
*Lateral & posterior wall of
LV
CAD IHD Angina pectoris
Definition of Coronary Artery Disease
All patients with
coronary artery
disease
(atherosclerosis) Cardiac disease as a result of
myocardial ischemia
(imbalance between oxygen
requirements and supply)
Symptoms of ischemia = angina pain
1. At rest = unstable angina
2. During exercise = stable angina
Coronary insufficiency is
characterized by:
Myocardial
requirements
Myocardial
supply
An Imbalance between requirements and
supply leading to Myocardial Ischemia
Causes of Coronary
Insufficiency:
Spasm
Atheroma
(90% of cases)
Stable plaque Plaque rupture or fissuration
Thrombus formation
Coronary atherosclerosis can
lead to myocardial ischemia
Myocardial ischemia with
Moderate/severe
exertion
Chronic Ischemic Disease
Myocardial
necrosis
Prolonged myocardial
ischemia with less
exertion/rest
Acute Ischaemic Events
Stable angina
Unstable angina Myocardial
Infarction
Stable plaque Plaque rupture or fissuration
Thrombus formation
Myocardial ischemia with
stable ischemic threshold
Myocardial
necrosis
Prolonged myocardial
ischemia with decreased
ischemic threshold
Coronary atherosclerosis can lead
to myocardial ischemia
ACS Pathophysiology
Disruptions of coronary artery
plaque -> platelet
activation/aggregation
/activation of coagulation
cascade -> endothelial
vasoconstriction ->intraluminal
thrombus/embolisation ->
obstruction -> ACS
Severity of coronary vessel
obstruction & extent of
myocardium involved
determines characteristics of
clinical presentation
Presentation of IHD
Stable angina
Unstable angina
Acute myocardial infarction (Acute MI)
* Non ST elevation MI (NSTEMI)
* ST elevation MI (STEMI)
Acute coronary syndrome (ACS)
Stable angina/Angina pectoris
Def. Chest discomfort due to transient
inadequate blood supply to the heart
(usually increased on exertion & relieved
by rest or sublingual GTN)
Characteristics of anginal pain :
* Location & Radiation
* Character
* Relation to exercise/provoking factors
* Duration of pain
Diagnosis
Clinical features (symptoms & sign)
Investigations:
* ECG: Resting ECG, Stress ECG
* Echocardiography
* Myocardial perfusion imaging (MPI)
* Coronary angiogram (CAG): CT CAG,
CAG
Acute coronary syndrome
It includes-
*Unstable angina- Ischaemia with no
myocardial damage
*Non ST elevation MI- with minimal damage /
partial thickness damage
(Non Q wave MI)
*ST elevation MI- Full thickness damage
(Q wave MI)
Unstable angina (UA):
Definition:
• Recent onset Angina
• Angina occuring with increasing
frequency
• Angina occurring with less exertion or at
rest
• Angina not rapidly relieved by S/L GTN
Unstable angina (UA):
Pathogenesis:
1. Plaque rupture &
2. Thrombus formation,
leading to incomplete &
intermittent coronary occlusion
with presence of collateral
channels. No myocardial necrosis
Unstable angina (UA):
Diagnosis of UA:
Clinical presentation: Typical chest pain
(Prolonged chest pain- Pain > 15 minutes)
Investigations:
ECG- May be normal / ST depression & /
T wave inversion
Electrical Signs of ischemia
ST-segment depression
P
Q
R
S
T
ST-segment
depression is present
if there is (at least):
• 1 mm of depression
• 80 ms’ duration
ST-segment
depression is an
objective sign of
reversible ischemia
mm
ms
Electrical Signs of ischemia
Other signs
Negative T wave, symmetrical
and pointed
Unstable angina (UA):
Investigations:
Cardiac enzymes/ Biochemical markers-
Usually normal
Echocardiography-
Wall motion abnormality
Echocardiography
Echocardiography
Coronary angiogram
Unstable angina (UA)
Treatment :
A. Medical management
B. Surgical management
A. Medical management Includes:
General management: Bed rest, O2, I/V line,
cont. ECG monitoring,
Drugs:
1) Nitrates- S/L & Oral, if needed I/V
2) Anti platelets
* Aspirin- 300 mg stat & 75 mg daily
* Clopidogrel- 300 mg stat & 75 mg daily
Unstable angina (UA):
3) I/V Morphine- For chest pain
4) Anticoagulants- * Low molecular weight Heparin
(Enoxaparin, Dalteparin)
* Unfractionated Heparin
5) Beta blockers- Metoprolol, Atenolol
6) Calcium antagonists- Diltiazem, Verapamil
7) Lipid lowering agents- Statins
Coronary intervention: PTCA / PCI with stenting
Surgical treatment: Coronary artery bypass graft
(CABG)
Myocardial infarction
Def:
Necrosis of a portion of heart muscle as a
result of an acute interruption of coronary
blood supply
PATHOLOGY:
Rupture of an atheromatous plaque, leads
to deposition of intra-coronary thrombus,
which leads in turn to coronary occlusion &
consequent necrosis of myocardium
Two types: Depending on ECG criteria
(ST elevation / Q wave)
1. Non ST elevation MI / Non Q wave MI
2. ST elevation MI / Q wave MI
Acute myocardial infarction
Non ST elevation MI (Non Q wave MI)
Pathophysiology-
* Plaque rupture & thrombus formation
* Incomplete & intermittent coronary
occlusion with presence of collateral
channels & some myocardial necrosis
Non ST elevation MI (Non Q wave MI)
Diagnosis:
A. Clinical presentation: Typical chest pain
B. Investigations:
* ECG- May be normal, ST depression & /
T wave inversion
* Cardiac enzymes/biochemical markers-
Elevated
* Echocardiography- Abnormal wall motion
* Coronary angiogram- CA occlusion
Non ST elevation MI (Non Q wave MI)
Treatment :
A. Medical management
B. Surgical management
Medical management: Includes- Hospitalization
* General management: O2, I/V line, ECG monitor
Drugs:
1) Nitrates- S/L, Oral. If needed I/V
2) Anti platelets- Aspirin, Clopidogrel
3) Anticoagulants- Heparin
* Low molecular weight Heparin (Enoxaparin)
* Unfractionated Heparin
Non ST elevation MI (Non Q wave MI)
Medical management….Contd:
4) Morphine I/V
5) Beta blockers
6) Calcium antagonists
7) Lipid lowering agents (Statins)
Coronary intervention: PTCA with stenting
B. Surgical treatment: Coronary artery bypass graft
(CABG)
MYOCARDIAL INFARCTION
ST Elevation MI
Def:
Necrosis of a portion of heart muscle as a
result of an acute interruption of coronary
blood supply
PATHOLOGY:
Rupture of an atheromatous plaque
Deposition of intra-coronary thrombus
Coronary occlusion
Necrosis of myocardium
Universal definition of myocardial
infarction
A combination of criteria is required to meet the diagnosis of acute
MI, namely the detection of an increase and/or decrease of a cardiac
biomarker, preferably high-sensitivity cardiac troponin, with at least
one value above the 99th percentile of the upper reference limit and
at least one of the following:
(1) Symptoms of ischaemia.
(2) New or presumed new significant ST-T wave changes or left
bundle branch block on 12-lead ECG.
(3) Development of pathological Q waves on ECG.
(4) Imaging evidence of new or presumed new loss of viable
myocardium or regional wall motion abnormality.
(5) Intracoronary thrombus detected on angiography or autopsy
Types
Type 1 MI
Type 1 MI is characterized by
atherosclerotic plaque rupture, ulceration,
fissure, erosion or dissection with resulting
intraluminal thrombus in one or more
coronary arteries leading to decreased
myocardial blood flow and/or distal
embolization and subsequent myocardial
necrosis.
Types-Contd
Type 2 MI
Type 2 MI is myocardial necrosis in which a
condition other than coronary plaque instability
contributes to an imbalance between myocardial
oxygen supply and demand. Mechanisms
include coronary artery spasm, coronary
endothelial dysfunction, tachyarrhythmias,
bradyarrhythmias, anaemia, respiratory failure,
hypotension and severe hypertension, injurious
effects of pharmacological agents and toxins.
Risk factors
The presence of any risk factor is
associated with doubling the risk of an MI.
Non Modifiable
Age
Gender
Family history
Modifiable
Smoking
Diabetes
Hypertension
Hyperlipidemia
Obesity
Physical Inactivity
MYOCARDIAL INFARCTION ( STE MI)
SYMPTOMS:
Prolonged chest pain (> 30 minutes)
Retrosternal, severe, compressing/
constricting/ tightness/heaviness
Radiates to- throat, jaw,
arms, epigastrium,back
Breathlessness
Nausia & vomiting
Anxiety (fear of impending death)
Syncope/collapse
MYOCARDIAL INFARCTION ( STE MI)
PHYSICAL SINGS:
1. Signs of sympathetic activation: eg
Pallor, sweating, tachycardia
2. Signs of vagal activation: eg
Vomiting, bradycardia
3. Pulse- Rate: Normal / Brady / tachy.
Rhythm: regular/irregular
Volume: Normal/small.
4. JVP- Normal / may be raised (RV infarct)
MYOCARDIAL INFARCTION (STE MI)
4. BP- May be normal / Hypotension or shock
5. Apex beat- Normal / feeble
6. Heart sound- Soft SI & S2. S3, S4 (if HF)
7. Murmur-
* Apical PSM (MR)-
due to papillary muscle dysfunction / rupture
* Lower parasternal PSM (VSR)-
due to ventricular septal rupture
MYOCARDIAL INFARCTION (STE MI)
contd.
8. Basal crepetation (pulmonary edema)
9. Pericardial rub (pericarditis)
10. Fever, leucocytosis, raised ESR
(myocardial necrosis)
MYOCARDIAL INFARCTION (MI)
D/D :
1) Unstable angina
2) Pericarditis
3) Aortic dissection
4) Pneumothorax
5) Pleurisy
6) Massive pulmonary embolism
7) Esophageal, other upper GI & biliary tract
disease
DIAGNOSIS:
1. Clinical features
• Symptoms
• Signs
2. Investigations-
• ECG
• Serum enzymes/Biochemical markers
• Blood counts
• CXR
• Echo
INVESTIGATIONS
1.ECG:
* ST segment elevation
* Pathological Q wave
* T wave inversion
a) Infrior MI: changes in
II, III, aVF
b) Anterior MI: VI- V6
c) Anteroseptal MI: VI-
V4 d)
d) Anterolateral MI. I,
aVL & V4- V6
e) Posterior MI: VI & V2
f) RV infarction: V4 R
INVESTIGATIONS
2) SERUM ENZYMES/
Biochemical markers:
a. Troponin T, Troponin I
Advantage- Rapid release
Early diagnosis
b. Creatine Kinase (CK)-
heart, brain & skeletal
muscle ,
CK-MB - cadiospecific
Rises within 6 hrs of onset.
Reaches peak in 18-24 hrs
Becomes normal after 72
hrs
INVESTIGATIONS
c. SGOT/AST:
Rises 12 hrs.
Peak 24-36 hrs,
Normal 3-5 days
d. LDH:
Rises later after MI
Peak- after 24-48 hrs
Normal after 1-3
weeks
INVESTIGATIONS
E) Blood count:
Leucocytosis
Raised ESR
F) Chest X-ray-
To detect pulmonary edema
G) Echocardiography:
RWMA
LV function
LV thrombus
Pericardial effusion
MR, VSR
MANAGEMENT OF ACUTE MI
A) ST segment elevation MI (STEMI)
Hospitalization in CCU & immediate initial
treatment:
1.Bed rest, I/V access, cont. ECG monitor-
2.02 inhalation (2-4 L/m)
3.Sublingual nitroglycerine
4.Anti platelet
300 mg soluble Aspirin (chew/crush)
300 mg Clopidogrel
MANAGEMENT OF ACUTE MI
4. Relief of pain with Morphine (3-5 mg i/v
every 5-15 minutely until relief of pain)
5. IV anti emetic: (Prochlorperazine)
8. Reperfusion : Pharmacological
a) IV thrombolytics
* Streptokinase- 1.5 million units in 100
ml of saline i/v over I hour
* Others- Urokinase, Alteplase (tPA)
INTRAVENOUS THROMBOLYSIS
Inclusion criteria:
 Symptoms of AMI
 ECG:
* ST elevation- I mm in limb leads & 2 mm in chest leads
(in 2 or more contiguous leads)
* New LBBB
 Time to therapy from onset of angina:
12 hr or less (< 6 hr more beneficial)
1st hr is the golden hr
Door to needle time (aim < 30 m)
INTRAVENOUS THROMBOLYSIS
Contraindication
1. Active internal bleeding
2. Previous sub arachnoid or intra
cerebral haemorrhage
3. Uncontrolled HTN (BP- 180/100 or >)
4. Recent surgery (Within 1 month)
5. Recent trauma including traumatic
resuscitation
6. Active PUD / any active bleeding
7. Pregnancy
MANAGEMENT OF ACUTE MI
b) Invasive procedure
1. Primary PTCA (percutaneous
transluminal coronary angioplasty)
with stenting
1. CABG (coronary artery by pass graft)
MANAGEMENT OF ACUTE MI
AFTER STABILIZATION….
DRUG:
1) Antiplatelet- Aspirin- 75 mg/day after meal
Clopidogrel- 75 mg/day
2) Beta-Blocker- Metoprolol- 50 mg/day
Atenolol- 25-50 mg/day
Carvedilol- 6.25-25 mg/day
MANAGEMENT OF ACUTE MI
Contd…
3. ACE inhibitors & ARBs-
Captopril, Ramipril
Valsartan, Losartan
4. Nitrates- Oral / IV
5. Lipid lowering agents-
Atorvastatin, Simvastatin
6.Treatment of complications: If any
COMPLICATIONS OF MI
I. Arrhythmia:
a. Ventricular- Ventricular ectopics
Ventricular tachycardia
Ventricular fibrillation
b. Supreventricular- SV Ectopis
Atrial flutter, SVT
Atrial fibrillation
c. Others- Sinus tachycardia
Sinus bradycardia
COMPLICATIONS OF MI
2. Heart block-
1st degree, 2nd degree & Complete HB
3. Bundle branch block-
LBBB, RBBB, Bi & Tri fascicular block
4. Heart failure- LVF, RVF (RVI)
COMPLICATIONS OF MI
5. Hypotension, cardiogenic shock
6. Mechanical complications-
MR,VSR, Cardiac rupture
7. Thrombo embolism
8. Pericarditis
COMPLICATIONS OF MI
Late complications-
1. Post MI angina, Re infarction
2. LV Aneurysm
3. Late arrhythmias
4. Thrombo embolism (systemic,
pulmonary)
5. Dressler’s syndrome
6. Heart failure
Secondary prevention:
1. Life style/ Risk factor modification
2. Drugs to be continued for indefinite
period
Aspirin/Clopidogrel
Beta-Blocker
Lipid lowering agent
ACE inhibitors
Future plan of management
For further evaluation-
CAG-To see coronary artery anatomy
* Accordingly 2 types of treatment
A) Medical management
* Drug treatment & /
* PTCA (Balloon angioplasty with stenting)
B) Surgical treatment- CABG
Interventional treatment
PTCA (Ballooning) Stenting
CABG
Presentation MI final by Dr Nasir Uddn

More Related Content

Similar to Presentation MI final by Dr Nasir Uddn

CARDIAC EMERGENCY
CARDIAC EMERGENCYCARDIAC EMERGENCY
CARDIAC EMERGENCY
Shalu Udhay
 
acute-coronary-syndromes1262-160118114208 (1).pdf
acute-coronary-syndromes1262-160118114208 (1).pdfacute-coronary-syndromes1262-160118114208 (1).pdf
acute-coronary-syndromes1262-160118114208 (1).pdf
jiregnaetichadako
 
7 ihd (2)
7 ihd (2)7 ihd (2)
7 ihd (2)
Engidaw Ambelu
 
Myocardial infarction
Myocardial infarction Myocardial infarction
Myocardial infarction
Aizaz919930
 
Pathology of heart
Pathology of heartPathology of heart
Acute coronary syndrome
Acute coronary syndrome Acute coronary syndrome
Acute coronary syndrome
Dee Evardone
 
Cardiovascular_System, Pharmacotherapeutics, Second Year D. Pharm
Cardiovascular_System, Pharmacotherapeutics, Second Year D. PharmCardiovascular_System, Pharmacotherapeutics, Second Year D. Pharm
Cardiovascular_System, Pharmacotherapeutics, Second Year D. Pharm
Dr. Kiran Dhamak
 
ACS Lecture.ppt
ACS Lecture.pptACS Lecture.ppt
ACS Lecture.ppt
Asgraf
 
Acute Coronary Syndrome
Acute Coronary SyndromeAcute Coronary Syndrome
Acute Coronary Syndrome
Manjeet Singh, Pharm D
 
Stemi by dr.mehelina
Stemi by dr.mehelinaStemi by dr.mehelina
Stemi by dr.mehelina
Nizam Uddin
 
Myocardia linfarction
Myocardia linfarction Myocardia linfarction
Myocardia linfarction
اوراق الياسمين
 
Acute Coronary Syndrome: MI
Acute Coronary Syndrome: MIAcute Coronary Syndrome: MI
Acute Coronary Syndrome: MI
shristi shrestha
 
Anaesthetic Management of a Patient with Ischaemic Heart Disease
Anaesthetic Management of a Patient with Ischaemic Heart DiseaseAnaesthetic Management of a Patient with Ischaemic Heart Disease
Anaesthetic Management of a Patient with Ischaemic Heart DiseaseZareer Tafadar
 
Pccn Review Part 1
Pccn Review Part 1Pccn Review Part 1
Pccn Review Part 1
Sherry Knowles
 
lecture 3 Cardiac alteration
lecture 3 Cardiac alteration lecture 3 Cardiac alteration
lecture 3 Cardiac alteration
ArabAlkhadam
 
Richa singh ecg in ischemic heart disease
Richa singh ecg in ischemic heart diseaseRicha singh ecg in ischemic heart disease
Richa singh ecg in ischemic heart disease
RICHASINGH470
 
Cardiovascular diseases modified
Cardiovascular diseases modifiedCardiovascular diseases modified
Cardiovascular diseases modifiedxtrm nurse
 
Acute coronary syndrome
Acute coronary syndromeAcute coronary syndrome
Acute coronary syndrome
dratin75
 
myocardial infarction
myocardial infarctionmyocardial infarction
myocardial infarction
Khalid286Jamal
 

Similar to Presentation MI final by Dr Nasir Uddn (20)

CARDIAC EMERGENCY
CARDIAC EMERGENCYCARDIAC EMERGENCY
CARDIAC EMERGENCY
 
acute-coronary-syndromes1262-160118114208 (1).pdf
acute-coronary-syndromes1262-160118114208 (1).pdfacute-coronary-syndromes1262-160118114208 (1).pdf
acute-coronary-syndromes1262-160118114208 (1).pdf
 
7 ihd (2)
7 ihd (2)7 ihd (2)
7 ihd (2)
 
Myocardial infarction
Myocardial infarction Myocardial infarction
Myocardial infarction
 
Pathology of heart
Pathology of heartPathology of heart
Pathology of heart
 
Acute coronary syndrome
Acute coronary syndrome Acute coronary syndrome
Acute coronary syndrome
 
Cardiovascular_System, Pharmacotherapeutics, Second Year D. Pharm
Cardiovascular_System, Pharmacotherapeutics, Second Year D. PharmCardiovascular_System, Pharmacotherapeutics, Second Year D. Pharm
Cardiovascular_System, Pharmacotherapeutics, Second Year D. Pharm
 
ACS Lecture.ppt
ACS Lecture.pptACS Lecture.ppt
ACS Lecture.ppt
 
Acute Coronary Syndrome
Acute Coronary SyndromeAcute Coronary Syndrome
Acute Coronary Syndrome
 
Stemi by dr.mehelina
Stemi by dr.mehelinaStemi by dr.mehelina
Stemi by dr.mehelina
 
Myocardia linfarction
Myocardia linfarction Myocardia linfarction
Myocardia linfarction
 
Acute Coronary Syndrome: MI
Acute Coronary Syndrome: MIAcute Coronary Syndrome: MI
Acute Coronary Syndrome: MI
 
Anaesthetic Management of a Patient with Ischaemic Heart Disease
Anaesthetic Management of a Patient with Ischaemic Heart DiseaseAnaesthetic Management of a Patient with Ischaemic Heart Disease
Anaesthetic Management of a Patient with Ischaemic Heart Disease
 
Pccn Review Part 1
Pccn Review Part 1Pccn Review Part 1
Pccn Review Part 1
 
lecture 3 Cardiac alteration
lecture 3 Cardiac alteration lecture 3 Cardiac alteration
lecture 3 Cardiac alteration
 
Richa singh ecg in ischemic heart disease
Richa singh ecg in ischemic heart diseaseRicha singh ecg in ischemic heart disease
Richa singh ecg in ischemic heart disease
 
Cardiovascular diseases modified
Cardiovascular diseases modifiedCardiovascular diseases modified
Cardiovascular diseases modified
 
Acute coronary syndrome
Acute coronary syndromeAcute coronary syndrome
Acute coronary syndrome
 
Acute Coronary Disease
Acute Coronary DiseaseAcute Coronary Disease
Acute Coronary Disease
 
myocardial infarction
myocardial infarctionmyocardial infarction
myocardial infarction
 

Recently uploaded

Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
Dr. Jyothirmai Paindla
 
Colonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implicationsColonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implications
Dr Maria Tamanna
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Dr. Madduru Muni Haritha
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Ayurveda ForAll
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
Dr. Jyothirmai Paindla
 
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptxSURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
Bright Chipili
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
chandankumarsmartiso
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
Swastik Ayurveda
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
Lighthouse Retreat
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 

Recently uploaded (20)

Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
 
Colonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implicationsColonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implications
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
 
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptxSURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 

Presentation MI final by Dr Nasir Uddn

  • 1. Ischaemic Heart Disease (IHD) Dr.A.T.M.Mahfuzul Hoque M D (Cardiology) Asst. Prof. Department of Cardiology Dhaka Medical College& Hospital
  • 2. Definition & clinical presentation of IHD : Def. of IHD: Disease of the heart muscle resulting from myocardial ischaemia Clinical presentation: 1) Stable Angina 2) Unstable Angina 3) Myocardial infarction (MI) - * Non ST elevation MI * ST elevation MI
  • 3. CORONARY CIRCULATION Two major coronary arteries 1. Right coronary artery *Arises from- RSV *Supplies- SA node, AV node & bundles, RV , LV inferior wall
  • 4. CORONARY CIRCULATION 2. Left coronary artery Arises from- LSV Two branches- a). Anterior descending Supplies- IVS & anterior wall of LV b). Left circumflex *Lateral & posterior wall of LV
  • 5. CAD IHD Angina pectoris Definition of Coronary Artery Disease All patients with coronary artery disease (atherosclerosis) Cardiac disease as a result of myocardial ischemia (imbalance between oxygen requirements and supply) Symptoms of ischemia = angina pain 1. At rest = unstable angina 2. During exercise = stable angina
  • 6. Coronary insufficiency is characterized by: Myocardial requirements Myocardial supply An Imbalance between requirements and supply leading to Myocardial Ischemia
  • 8. Stable plaque Plaque rupture or fissuration Thrombus formation Coronary atherosclerosis can lead to myocardial ischemia Myocardial ischemia with Moderate/severe exertion Chronic Ischemic Disease Myocardial necrosis Prolonged myocardial ischemia with less exertion/rest Acute Ischaemic Events
  • 9. Stable angina Unstable angina Myocardial Infarction Stable plaque Plaque rupture or fissuration Thrombus formation Myocardial ischemia with stable ischemic threshold Myocardial necrosis Prolonged myocardial ischemia with decreased ischemic threshold Coronary atherosclerosis can lead to myocardial ischemia
  • 10. ACS Pathophysiology Disruptions of coronary artery plaque -> platelet activation/aggregation /activation of coagulation cascade -> endothelial vasoconstriction ->intraluminal thrombus/embolisation -> obstruction -> ACS Severity of coronary vessel obstruction & extent of myocardium involved determines characteristics of clinical presentation
  • 11.
  • 12. Presentation of IHD Stable angina Unstable angina Acute myocardial infarction (Acute MI) * Non ST elevation MI (NSTEMI) * ST elevation MI (STEMI) Acute coronary syndrome (ACS)
  • 13. Stable angina/Angina pectoris Def. Chest discomfort due to transient inadequate blood supply to the heart (usually increased on exertion & relieved by rest or sublingual GTN) Characteristics of anginal pain : * Location & Radiation * Character * Relation to exercise/provoking factors * Duration of pain
  • 14. Diagnosis Clinical features (symptoms & sign) Investigations: * ECG: Resting ECG, Stress ECG * Echocardiography * Myocardial perfusion imaging (MPI) * Coronary angiogram (CAG): CT CAG, CAG
  • 15. Acute coronary syndrome It includes- *Unstable angina- Ischaemia with no myocardial damage *Non ST elevation MI- with minimal damage / partial thickness damage (Non Q wave MI) *ST elevation MI- Full thickness damage (Q wave MI)
  • 16. Unstable angina (UA): Definition: • Recent onset Angina • Angina occuring with increasing frequency • Angina occurring with less exertion or at rest • Angina not rapidly relieved by S/L GTN
  • 17. Unstable angina (UA): Pathogenesis: 1. Plaque rupture & 2. Thrombus formation, leading to incomplete & intermittent coronary occlusion with presence of collateral channels. No myocardial necrosis
  • 18. Unstable angina (UA): Diagnosis of UA: Clinical presentation: Typical chest pain (Prolonged chest pain- Pain > 15 minutes) Investigations: ECG- May be normal / ST depression & / T wave inversion
  • 19. Electrical Signs of ischemia ST-segment depression P Q R S T ST-segment depression is present if there is (at least): • 1 mm of depression • 80 ms’ duration ST-segment depression is an objective sign of reversible ischemia mm ms
  • 20. Electrical Signs of ischemia Other signs Negative T wave, symmetrical and pointed
  • 21. Unstable angina (UA): Investigations: Cardiac enzymes/ Biochemical markers- Usually normal Echocardiography- Wall motion abnormality
  • 25.
  • 26. Unstable angina (UA) Treatment : A. Medical management B. Surgical management A. Medical management Includes: General management: Bed rest, O2, I/V line, cont. ECG monitoring, Drugs: 1) Nitrates- S/L & Oral, if needed I/V 2) Anti platelets * Aspirin- 300 mg stat & 75 mg daily * Clopidogrel- 300 mg stat & 75 mg daily
  • 27. Unstable angina (UA): 3) I/V Morphine- For chest pain 4) Anticoagulants- * Low molecular weight Heparin (Enoxaparin, Dalteparin) * Unfractionated Heparin 5) Beta blockers- Metoprolol, Atenolol 6) Calcium antagonists- Diltiazem, Verapamil 7) Lipid lowering agents- Statins Coronary intervention: PTCA / PCI with stenting Surgical treatment: Coronary artery bypass graft (CABG)
  • 28. Myocardial infarction Def: Necrosis of a portion of heart muscle as a result of an acute interruption of coronary blood supply PATHOLOGY: Rupture of an atheromatous plaque, leads to deposition of intra-coronary thrombus, which leads in turn to coronary occlusion & consequent necrosis of myocardium
  • 29. Two types: Depending on ECG criteria (ST elevation / Q wave) 1. Non ST elevation MI / Non Q wave MI 2. ST elevation MI / Q wave MI Acute myocardial infarction
  • 30. Non ST elevation MI (Non Q wave MI) Pathophysiology- * Plaque rupture & thrombus formation * Incomplete & intermittent coronary occlusion with presence of collateral channels & some myocardial necrosis
  • 31. Non ST elevation MI (Non Q wave MI) Diagnosis: A. Clinical presentation: Typical chest pain B. Investigations: * ECG- May be normal, ST depression & / T wave inversion * Cardiac enzymes/biochemical markers- Elevated * Echocardiography- Abnormal wall motion * Coronary angiogram- CA occlusion
  • 32. Non ST elevation MI (Non Q wave MI) Treatment : A. Medical management B. Surgical management Medical management: Includes- Hospitalization * General management: O2, I/V line, ECG monitor Drugs: 1) Nitrates- S/L, Oral. If needed I/V 2) Anti platelets- Aspirin, Clopidogrel 3) Anticoagulants- Heparin * Low molecular weight Heparin (Enoxaparin) * Unfractionated Heparin
  • 33. Non ST elevation MI (Non Q wave MI) Medical management….Contd: 4) Morphine I/V 5) Beta blockers 6) Calcium antagonists 7) Lipid lowering agents (Statins) Coronary intervention: PTCA with stenting B. Surgical treatment: Coronary artery bypass graft (CABG)
  • 34. MYOCARDIAL INFARCTION ST Elevation MI Def: Necrosis of a portion of heart muscle as a result of an acute interruption of coronary blood supply PATHOLOGY: Rupture of an atheromatous plaque Deposition of intra-coronary thrombus Coronary occlusion Necrosis of myocardium
  • 35. Universal definition of myocardial infarction A combination of criteria is required to meet the diagnosis of acute MI, namely the detection of an increase and/or decrease of a cardiac biomarker, preferably high-sensitivity cardiac troponin, with at least one value above the 99th percentile of the upper reference limit and at least one of the following: (1) Symptoms of ischaemia. (2) New or presumed new significant ST-T wave changes or left bundle branch block on 12-lead ECG. (3) Development of pathological Q waves on ECG. (4) Imaging evidence of new or presumed new loss of viable myocardium or regional wall motion abnormality. (5) Intracoronary thrombus detected on angiography or autopsy
  • 36. Types Type 1 MI Type 1 MI is characterized by atherosclerotic plaque rupture, ulceration, fissure, erosion or dissection with resulting intraluminal thrombus in one or more coronary arteries leading to decreased myocardial blood flow and/or distal embolization and subsequent myocardial necrosis.
  • 37. Types-Contd Type 2 MI Type 2 MI is myocardial necrosis in which a condition other than coronary plaque instability contributes to an imbalance between myocardial oxygen supply and demand. Mechanisms include coronary artery spasm, coronary endothelial dysfunction, tachyarrhythmias, bradyarrhythmias, anaemia, respiratory failure, hypotension and severe hypertension, injurious effects of pharmacological agents and toxins.
  • 38. Risk factors The presence of any risk factor is associated with doubling the risk of an MI. Non Modifiable Age Gender Family history
  • 40. MYOCARDIAL INFARCTION ( STE MI) SYMPTOMS: Prolonged chest pain (> 30 minutes) Retrosternal, severe, compressing/ constricting/ tightness/heaviness Radiates to- throat, jaw, arms, epigastrium,back Breathlessness Nausia & vomiting Anxiety (fear of impending death) Syncope/collapse
  • 41. MYOCARDIAL INFARCTION ( STE MI) PHYSICAL SINGS: 1. Signs of sympathetic activation: eg Pallor, sweating, tachycardia 2. Signs of vagal activation: eg Vomiting, bradycardia 3. Pulse- Rate: Normal / Brady / tachy. Rhythm: regular/irregular Volume: Normal/small. 4. JVP- Normal / may be raised (RV infarct)
  • 42. MYOCARDIAL INFARCTION (STE MI) 4. BP- May be normal / Hypotension or shock 5. Apex beat- Normal / feeble 6. Heart sound- Soft SI & S2. S3, S4 (if HF) 7. Murmur- * Apical PSM (MR)- due to papillary muscle dysfunction / rupture * Lower parasternal PSM (VSR)- due to ventricular septal rupture
  • 43. MYOCARDIAL INFARCTION (STE MI) contd. 8. Basal crepetation (pulmonary edema) 9. Pericardial rub (pericarditis) 10. Fever, leucocytosis, raised ESR (myocardial necrosis)
  • 44. MYOCARDIAL INFARCTION (MI) D/D : 1) Unstable angina 2) Pericarditis 3) Aortic dissection 4) Pneumothorax 5) Pleurisy 6) Massive pulmonary embolism 7) Esophageal, other upper GI & biliary tract disease
  • 45. DIAGNOSIS: 1. Clinical features • Symptoms • Signs 2. Investigations- • ECG • Serum enzymes/Biochemical markers • Blood counts • CXR • Echo
  • 46. INVESTIGATIONS 1.ECG: * ST segment elevation * Pathological Q wave * T wave inversion a) Infrior MI: changes in II, III, aVF b) Anterior MI: VI- V6 c) Anteroseptal MI: VI- V4 d) d) Anterolateral MI. I, aVL & V4- V6 e) Posterior MI: VI & V2 f) RV infarction: V4 R
  • 47. INVESTIGATIONS 2) SERUM ENZYMES/ Biochemical markers: a. Troponin T, Troponin I Advantage- Rapid release Early diagnosis b. Creatine Kinase (CK)- heart, brain & skeletal muscle , CK-MB - cadiospecific Rises within 6 hrs of onset. Reaches peak in 18-24 hrs Becomes normal after 72 hrs
  • 48. INVESTIGATIONS c. SGOT/AST: Rises 12 hrs. Peak 24-36 hrs, Normal 3-5 days d. LDH: Rises later after MI Peak- after 24-48 hrs Normal after 1-3 weeks
  • 49. INVESTIGATIONS E) Blood count: Leucocytosis Raised ESR F) Chest X-ray- To detect pulmonary edema G) Echocardiography: RWMA LV function LV thrombus Pericardial effusion MR, VSR
  • 50. MANAGEMENT OF ACUTE MI A) ST segment elevation MI (STEMI) Hospitalization in CCU & immediate initial treatment: 1.Bed rest, I/V access, cont. ECG monitor- 2.02 inhalation (2-4 L/m) 3.Sublingual nitroglycerine 4.Anti platelet 300 mg soluble Aspirin (chew/crush) 300 mg Clopidogrel
  • 51. MANAGEMENT OF ACUTE MI 4. Relief of pain with Morphine (3-5 mg i/v every 5-15 minutely until relief of pain) 5. IV anti emetic: (Prochlorperazine) 8. Reperfusion : Pharmacological a) IV thrombolytics * Streptokinase- 1.5 million units in 100 ml of saline i/v over I hour * Others- Urokinase, Alteplase (tPA)
  • 52. INTRAVENOUS THROMBOLYSIS Inclusion criteria:  Symptoms of AMI  ECG: * ST elevation- I mm in limb leads & 2 mm in chest leads (in 2 or more contiguous leads) * New LBBB  Time to therapy from onset of angina: 12 hr or less (< 6 hr more beneficial) 1st hr is the golden hr Door to needle time (aim < 30 m)
  • 53. INTRAVENOUS THROMBOLYSIS Contraindication 1. Active internal bleeding 2. Previous sub arachnoid or intra cerebral haemorrhage 3. Uncontrolled HTN (BP- 180/100 or >) 4. Recent surgery (Within 1 month) 5. Recent trauma including traumatic resuscitation 6. Active PUD / any active bleeding 7. Pregnancy
  • 54. MANAGEMENT OF ACUTE MI b) Invasive procedure 1. Primary PTCA (percutaneous transluminal coronary angioplasty) with stenting 1. CABG (coronary artery by pass graft)
  • 55. MANAGEMENT OF ACUTE MI AFTER STABILIZATION…. DRUG: 1) Antiplatelet- Aspirin- 75 mg/day after meal Clopidogrel- 75 mg/day 2) Beta-Blocker- Metoprolol- 50 mg/day Atenolol- 25-50 mg/day Carvedilol- 6.25-25 mg/day
  • 56. MANAGEMENT OF ACUTE MI Contd… 3. ACE inhibitors & ARBs- Captopril, Ramipril Valsartan, Losartan 4. Nitrates- Oral / IV 5. Lipid lowering agents- Atorvastatin, Simvastatin 6.Treatment of complications: If any
  • 57. COMPLICATIONS OF MI I. Arrhythmia: a. Ventricular- Ventricular ectopics Ventricular tachycardia Ventricular fibrillation b. Supreventricular- SV Ectopis Atrial flutter, SVT Atrial fibrillation c. Others- Sinus tachycardia Sinus bradycardia
  • 58. COMPLICATIONS OF MI 2. Heart block- 1st degree, 2nd degree & Complete HB 3. Bundle branch block- LBBB, RBBB, Bi & Tri fascicular block 4. Heart failure- LVF, RVF (RVI)
  • 59. COMPLICATIONS OF MI 5. Hypotension, cardiogenic shock 6. Mechanical complications- MR,VSR, Cardiac rupture 7. Thrombo embolism 8. Pericarditis
  • 60. COMPLICATIONS OF MI Late complications- 1. Post MI angina, Re infarction 2. LV Aneurysm 3. Late arrhythmias 4. Thrombo embolism (systemic, pulmonary) 5. Dressler’s syndrome 6. Heart failure
  • 61. Secondary prevention: 1. Life style/ Risk factor modification 2. Drugs to be continued for indefinite period Aspirin/Clopidogrel Beta-Blocker Lipid lowering agent ACE inhibitors
  • 62. Future plan of management For further evaluation- CAG-To see coronary artery anatomy * Accordingly 2 types of treatment A) Medical management * Drug treatment & / * PTCA (Balloon angioplasty with stenting) B) Surgical treatment- CABG
  • 63.
  • 64.